Hwan Suck Chung

Title: Hwan Suck Chung: Inventor in Tumor Immunotherapy

Introduction

Hwan Suck Chung is an inventor based in Daegu, South Korea. He is associated with the Korea Institute of Oriental Medicine and is named on 1 patent concerning a potential approach to inhibiting tumor proliferation.

Latest Patents

Chung’s patent, “Composition for Inhibiting Proliferation of Tumor Comprising Extract as Effective Component,” describes a composition intended to support anti-tumor immune activity. According to the provided patent description, the extract binds to PD-L1 on cancer cells, blocking its interaction with PD-1 on T cells. This mechanism is reported to activate T cells and inhibit tumor proliferation.

The description also reports anti-tumor immune activity in a humanized PD-1 animal model using MC38 colorectal cancer cells expressing human PD-L1. It further notes a synergistic effect when the composition is administered alongside anti-cancer agents.

Career Highlights

Chung’s listed work connects research at the Korea Institute of Oriental Medicine with an immunotherapy strategy focused on the PD-1/PD-L1 pathway. The patent description highlights preclinical findings, including tumor-growth inhibition and potential combination effects with anti-cancer treatments.

Collaborations

Ji Hye Kim and Jang Gi Choi are identified as Chung’s coworkers. Their names are associated with his professional context, though the provided information does not specify their roles in the patent.

Conclusion

Hwan Suck Chung’s patent presents an extract-based approach to targeting PD-L1 and stimulating anti-tumor immune activity, with reported preclinical findings that include potential synergy with anti-cancer agents.